Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson’s disease via suppression of LASP1

[1]  G. Zhen,et al.  microRNA‐218‐5p plays a protective role in eosinophilic airway inflammation via targeting δ‐catenin, a novel catenin in asthma , 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  M. Li,et al.  miR-21 deficiency contributes to the impaired protective effects of obese rat mesenchymal stem cell-derived exosomes against spinal cord injury. , 2019, Biochimie.

[3]  Kuai Yu,et al.  The Nebulin Family LIM and SH3 Proteins Regulate Postsynaptic Development and Function , 2019, The Journal of Neuroscience.

[4]  K. Hamberg,et al.  Activities of daily living in Parkinson's disease: Time/gender perspective , 2019, Acta neurologica Scandinavica.

[5]  Xizeng Feng,et al.  The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson’s disease in mice , 2019, Behavioural Brain Research.

[6]  Yang Liu,et al.  Gender differences in prevalence of LRRK2-associated Parkinson disease: A meta-analysis of observational studies , 2019, Neuroscience Letters.

[7]  K. Chaudhuri,et al.  Acupuncture Effect and Mechanism for Treating Pain in Patients With Parkinson's Disease , 2019, Front. Neurol..

[8]  Yu Ma,et al.  The development of visual neuroimaging research of acupuncture in the treatment of Parkinson’s disease , 2019, Brain Science Advances.

[9]  A. Singleton,et al.  SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[10]  K. Yung,et al.  Roles of Glutamate Receptors in Parkinson’s Disease , 2019, International journal of molecular sciences.

[11]  P. Bie,et al.  ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis , 2019, Journal of experimental & clinical cancer research : CR.

[12]  Zhentao Zhang,et al.  The gut-brain axis in the pathogenesis of Parkinson’s disease , 2019, Brain Science Advances.

[13]  K. Ting,et al.  MiRNA‐218 regulates osteoclast differentiation and inflammation response in periodontitis rats through Mmp9 , 2019, Cellular microbiology.

[14]  Jiajun Chen,et al.  Identification of Critical Genes and miRNAs Associated with the Development of Parkinson’s Disease , 2018, Journal of Molecular Neuroscience.

[15]  A. Björklund,et al.  BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats , 2017, Experimental Neurology.

[16]  M. Fang,et al.  Hypoxia-inducible microRNA-218 inhibits trophoblast invasion by targeting LASP1: Implications for preeclampsia development. , 2017, The international journal of biochemistry & cell biology.

[17]  Luca Weis,et al.  Anatomical and functional correlates of persistent pain in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[18]  Shawn P. Driscoll,et al.  Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure , 2015, Science.

[19]  R. He,et al.  DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells* , 2015, The Journal of Biological Chemistry.

[20]  Jing-bo Li,et al.  Andrographolide antagonizes cigarette smoke extract-induced inflammatory response and oxidative stress in human alveolar epithelial A549 cells through induction of microRNA-218 , 2013, Experimental lung research.

[21]  Danail Bonchev,et al.  A Network View on Parkinson's Disease , 2013, Computational and structural biotechnology journal.

[22]  D. Zillikens,et al.  Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR‐induced depletion, and protects against the formation of DNA damage (8‐hydroxy‐2'‐deoxyguanosine) in ex vivo human skin , 2013, Journal of pineal research.

[23]  N. Seki,et al.  Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. , 2012, Urologic oncology.

[24]  A. Fève.  Current status of tyrosine hydroxylase in management of Parkinson's disease. , 2012, CNS & neurological disorders drug targets.

[25]  Z. Pu,et al.  [Effects of scalp catgut embedding on SOD, NO, MDA in the rat with Parkinson's disease]. , 2007, Zhongguo zhen jiu = Chinese acupuncture & moxibustion.

[26]  J. Yates,et al.  Actin‐binding proteins in a postsynaptic preparation: Lasp‐1 is a component of central nervous system synapses and dendritic spines , 2004, Journal of neuroscience research.

[27]  C. Duan,et al.  [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease]. , 2004, Zhonghua yi xue za zhi.

[28]  B. Ames,et al.  Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. , 2002, Neurotoxicology.

[29]  N. J. Malik,et al.  Linkage relationships and allelic associations of the cystic fibrosis locus and four marker loci , 1987, Human Genetics.

[30]  M. Olchik,et al.  Validation of Content and Reliability of the Protocol for the Evaluation of Acquired Speech Disorders in Individuals with Parkinson's Disease (PADAF). , 2019, CoDAS.

[31]  K. Yung,et al.  Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease , 2019, Journal of Neurorestoratology.